Vaccine R&D: International Vaccine Congress

Pierre A. MORGON

Pierre A. MORGON

CEO of MRGN Advisors
Lyon University
Switzerland

Biography

He is Chairman of the Board of Virometix, as well as Non-Executive Director to the Boards of Theradiag, of Eurocine Vaccines, and of Vaccitech. Pierre has over 30 years of experience in the global life science industry, especially with specialty care, vaccines and immunotherapy, at the helm of international operations, in C-level positions at global level in multinational corporations and as CEO of start-up companies.


Research Interest

Through these local and global positions, Pierre have acquired direct experience with blockbuster products in diverse markets (primary care, specialty care, hospital, vaccines, and biotechnology), geographies (US, Europe, Japan, China, India, Emerging Markets) and organizations.

Related Conferenes